Human endogenous RNAs: Implications for the immunomodulation of Toll-like receptor 3

Amarante,Marla   Karine; Maeda Oda,Julie  Massayo; Vissoci Reiche,Edna   Maria; Kaminami Morimoto,Helena; Nobrega Aoki,Mateus; Ehara Watanabe,Maria   Angelica

doi:10.3892/etm.2011.303

Human endogenous RNAs: Implications for the immunomodulation of Toll-like receptor 3

Authors:
- Marla Karine Amarante
- Julie Massayo Maeda Oda
- Edna Maria Vissoci Reiche
- Helena Kaminami Morimoto
- Mateus Nobrega Aoki
- Maria Angelica Ehara Watanabe
View Affiliations

Affiliations: Centro de Ciências Biológicas, Departamento de Ciências Patológicas, Laboratório de Genética Molecular e Imunologia, Universidade Estadual de Londrina, CEP 86051-970, Londrina, Paraná, Brazil, Departamento de Patológia, Laboratório de Genética Molecular e Imunologia, Universidade Estadual de Londrina, CEP 86051-970, Londrina, Paraná, Brazil, Department of Biochemistry, Chemistry Institute, University of São Paulo, São Paulo, Brazil
Published online on: June 30, 2011 https://doi.org/10.3892/etm.2011.303
Pages: 925-929

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Toll-like receptors (TLRs), a family of mammalian receptors, are able to recognize nucleic acids. TLR3 recognizes double‑stranded (ds)RNA, a product of the replication of certain viruses. Polyinosinic-polycytidylic acid, referred to as poly(I:C), an analog of viral dsRNA, interacts with TLR3 thereby eliciting immunoinflammatory responses characteristic of viral infection or down‑regulating the expression of chemokine receptor CXCR4. It is known that dsRNA also directly activates interferon (IFN)-induced enzymes, such as the RNA-dependent protein kinase (PKR). In the present study, the mRNA expression of TLR3, CXCR4, IFNγ and PKR was investigated in a culture of peripheral blood mononuclear cells (PBMCs) stimulated with poly(I:C) and endogenous RNA from human PBMCs. No cytotoxic effect on the cells or on the proliferation of CD3+, CD4+ and CD8+ cells was observed. TLR3 expression in the PBMCs in the presence of poly(I:C) was up-regulated 9.5‑fold, and TLR3 expression in the PBMCs treated with endogenous RNA was down‑regulated 1.8‑fold (p=0.002). The same trend was observed for IFNγ where in the presence of poly(I:C) an 8.7-fold increase was noted and in the presence of endogenous RNA a 3.1-fold decrease was observed. In the culture activated with poly(I:C), mRNA expression of CXCR4 increased 8.0‑fold and expression of PKR increased 33.0‑fold. Expression of these genes decreased in the culture treated with endogenous RNA when compared to the culture without stimulus. Thus, high expression of mRNA for TLR3, IFNγ, CXCR4 and PKR was observed in the presence of poly(I:C) and low expression was observed in the cells cultured with endogenous RNA. In conclusion, TLR3 may play major physiological roles that are not in the context of viral infection. It is possible that RNA released from cells could contain enough double‑stranded structures to regulate cell activation. The involvement of endogenous RNA in endogenous gene expression and its implications in the regulation thereof, are still being studied, and will have significant implications in the future.

View Figures

View References

1.	Medzhitov R: Toll-like receptors and innate immunity. Nat Rev Immunol. 1:135–145. 2001. View Article : Google Scholar : PubMed/NCBI
2.	Alexopoulou L, Holt AC, Medzhitov R and Flavell RA: Recognition of double-stranded RNA and activation of NF-κB by analysis of Toll-like receptor 3. Nature. 413:732–738. 2001.
3.	Wang T, Town T, Alexopoulou L, Anderson JF, Fikrig E and Flavell RA: Toll-like receptor 3 mediates West Nile vírus entry into the brain causing lethal encephalitis. Nat Med. 10:1366–1373. 2004.PubMed/NCBI
4.	Cavassani KA, Ishii M, Wen H, et al: TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events. J Exp Med. 205:2609–2621. 2008. View Article : Google Scholar : PubMed/NCBI
5.	Benwell RK, Hruska JE, Fritsche KL and Lee DR: Double stranded RNA - relative to other TLR ligand-activated dendritic cells induce extremely polarized human Th1 responses. Cell Immunol. 264:119–126. 2010. View Article : Google Scholar
6.	Lacour J, Laplanche A, Malafosse M, et al: Polyadenylic-polyuridylic acid as an adjuvant in resectable colorectal carcinoma: a 6 1/2 year follow-up analysis of a multicentric double blind randomized trial. Eur J Surg Oncol. 18:599–604. 1992.
7.	Laplanche A, Alzieu L, Delozier T, et al: Polyadenylic-polyuridylic acid plus locoregional radiotherapy versus chemotherapy with CMF in operable breast cancer: a 14 year follow-up analysis of a randomized trial of the Federation Nationale des Centres de Lutte contre le Cancer (FNCLCC). Breast Cancer Res Treat. 64:189–191. 2000.
8.	Adams M, Navabi H, Croston D, et al: The rationale for combined chemo/immunotherapy using a Toll-like receptor 3 (TLR3) agonist and tumour-derived exosomes in advanced ovarian cancer. Vaccine. 23:2374–2378. 2005. View Article : Google Scholar : PubMed/NCBI
9.	Le UM, Yanasarn N, Lohr CV, Fischer KA and Cui Z: Tumor chemoimmunotherapy using gemcitabine and a synthetic dsRNA. Cancer Biol Ther. 7:440–447. 2008. View Article : Google Scholar : PubMed/NCBI
10.	Salaun B, Coste I, Rissoan MC, Lebecque SJ and Renno T: TLR3 can directly trigger apoptosis in human cancer cells. J Immunol. 176:4894–4901. 2006. View Article : Google Scholar : PubMed/NCBI
11.	Salaun B, Lebecque S, Matikainen S, Rimoldi D and Romero P: Toll-like receptor 3 expressed by melanoma cells as a target for therapy? Clin Cancer Res. 13:4565–4574. 2007. View Article : Google Scholar : PubMed/NCBI
12.	Taura M, Fukuda R, Suico MA and Eguma A: TLR3 induction by anticancer drugs potentiates poly I:C-induced tumor cell apoptosis. Cancer Sci. 101:1610–1617. 2010. View Article : Google Scholar : PubMed/NCBI
13.	Zhang Y, Sun R and Liu B: TLR3 activation inhibits nasopharyngeal carcinoma metastasis via downregulation of chemokine receptor CXCR4. Cancer Biol Ther. 8:1826–1830. 2009. View Article : Google Scholar : PubMed/NCBI
14.	Nallagatla SR, Toroney R and Bevilacqua PC: A brilliant disguise for self RNA: 5′-end and internal modifications of primary transcripts suppress elements of innate immunity. RNA Biol. 5:140–144. 2008.PubMed/NCBI
15.	Kato H, Takeuchi O, Mikamo-Satoh E, et al: Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J Exp Med. 205:1601–1610. 2008. View Article : Google Scholar
16.	Kumar H, Kawai T and Akira S: Pathogen recognition in the innate immune response. Biochem J. 420:1–16. 2009. View Article : Google Scholar : PubMed/NCBI
17.	Li X, Lu C, Stewart M, Xu H, Strong RK, Igumenova T and Li P: Structural basis of double-stranded RNA recognition by the RIG-I like receptor MDA5. Arch Biochem Biophys. 488:23–33. 2009. View Article : Google Scholar : PubMed/NCBI
18.	Gay RJ, McComb RB and Bowers GNJ: Optimum reaction conditions for human lactate dehydrogenase isoenzymes as they affect total lactate dehydrogenase activity. Clin Chem. 14:740–753. 1968.
19.	Amarante MK, De Lucca FL, Oliveira CEC, Pelegrinelli Fungaro MH, Reiche EM, Muxel SM and Ehara Watanabe MA: Expression of noncoding mRNA in humam blood cells activated with synthetic peptide of HIV. Blood Cells Mol Dis. 5:286–290. 2005. View Article : Google Scholar : PubMed/NCBI
20.	Pfaffl MW: A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29:45–51. 2001. View Article : Google Scholar : PubMed/NCBI
21.	Brentano F, Schorr O, Gay RE, Gay S and Kyburz D: RNA released from necrotic synovial fluid cells activates rheumatoid arthritis synovial fibroblasts via toll-like receptor 3. Arthritis Rheum. 52:2656–2665. 2005. View Article : Google Scholar : PubMed/NCBI
22.	Ben-Asouli Y, Banai Y, Pel-Or Y, Shir A and Kaempfer R: Human interferon-gamma mRNA autoregulates its translation through a pseudoknot that activates the interferon-inducible protein kinase PKR. Cell. 108:221–232. 2002. View Article : Google Scholar : PubMed/NCBI
23.	Erdmann VA, Barciszewska MZ, Szymanski M, Hochberg A, De Groot N and Barciszewska J: The non-coding RNAs as regulators. Nucleic Acids Res. 29:189–193. 2001. View Article : Google Scholar
24.	Szymanski M and Barciszewski J: Beyond the proteome: non-coding regulatory RNAs. Genome Biol. 3:1–8. 2008.
25.	Tabiasco J, Devevre E, Rufer N and Salaun B: Human effector CD8⁺ T lymphocytes express TLR3 as a functional coreceptor. J Immunol. 177:8708–8713. 2006.
26.	Vercammen E, Staal J and Beyaert R: Sensing of viral infection and activation of innate immunity by Toll-like receptor 3. Clin Microbiol Rev. 21:13–25. 2008. View Article : Google Scholar : PubMed/NCBI
27.	Karikó K, Ni H, Capodici J, Lamphier M and Weissman D: mRNA is an endogenous ligand for Toll-like receptor 3. J Biol Chem. 279:12542–12550. 2004.PubMed/NCBI
28.	Clemens MJ: PKR – a protein kinase regulated by double-stranded RNA. Int J Biochem Cell Biol. 29:945–949. 1997.
29.	Nomi N, Kodama S and Suzuki M: Toll-like receptor 3 signaling induces apoptosis in human head and neck cancer via survivin associated pathway. Oncol Rep. 24:225–231. 2010.PubMed/NCBI
30.	Karikó K, Buckstein M, Ni H and Weissman D: Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity. 23:165–175. 2005.PubMed/NCBI
31.	Amarante MK and Watanabe MAE: Toll-like receptor 3: involvement with exogenous and endogenous RNA. Int Rev Immunol. 29:557–573. 2010. View Article : Google Scholar : PubMed/NCBI